In the United States, around 1.8% of children have been diagnosed with autism, a figure that has seen a significant increase, more than doubling over the last twenty years. The Centers for Disease Control and Prevention (CDC) noted in 2021 that about 1 in 44 children in the U.S. are identified with an autism spectrum disorder (ASD), with the rate being nearly 1 in 27 for boys and 1 in 116 for girls. Autism affects individuals across all racial and socioeconomic backgrounds. With this rising prevalence, an increasing number of parents are exploring alternative treatments to mitigate autism's core symptoms.

Conventional medications and therapies have often not met the expectations for numerous individuals with autism and their families, leading to a search for more effective interventions. Hyperbaric therapy has emerged as a notable alternative, gaining attention from both parents and healthcare professionals for its potential in alleviating ASD symptoms.

This non-invasive approach involves one-hour sessions where both the child and a parent can enter a hyperbaric chamber to be exposed to elevated oxygen levels. Such treatment has shown promise in reducing inflammation and enhancing cognitive function, offering significant benefits to thousands of patients with autism spectrum disorder.